ICICI Securities Ltd | Retail Equity Research Revenues grew 41% YoY to | 409 crore (I-direct estimates: | 381 crore) mainly due to lower base of Q4FY17 (fire incident impact) and strong growth in chemical development and discovery services supported by biologics business EBITDA margins declined 281 bps to 31.6% YoY (I-direct estimate: 33.1%) mainly due to higher other expenses. EBITDA increased 29% YoY to | 129 crore (I-direct estimates: | 126 crore...